News for 'SAR technologies'

'Economy can bounce back, but the dead won't come back'

'Economy can bounce back, but the dead won't come back'

Rediff.com6 May 2021

'Unless some serious steps like complete closedown are taken, it will have disastrous consequences.'

20 passengers from UK test positive for COVID-19

20 passengers from UK test positive for COVID-19

Rediff.com22 Dec 2020

According to SOP, those testing positive will be isolated in a separate unit of an institutional facility.

As a nation we unfortunately do not value lives

As a nation we unfortunately do not value lives

Rediff.com1 Aug 2016

'Other countries go out on a limb to save even a single life.' 'What to talk of civilian accidents and disasters, even our military does not have a priority for Combat Search and Rescue,' says Group Captain P I Muralidharan (retd).

'No indication Omicron is more infectious or lethal'

'No indication Omicron is more infectious or lethal'

Rediff.com30 Nov 2021

'Mortality or hospitalisation has not increased in South Africa because of the new variant.' 'There is nothing to show so far that it is more infectious.' 'I am of the opinion that at the moment, there is no reason to panic.'

10 small economies hold 85% of $15 trn phantom FDI

10 small economies hold 85% of $15 trn phantom FDI

Rediff.com11 Sep 2019

Phantom FDI refers to investments that pass through shell companies that have no real business activities and are tailor-made to cut tax liabilities.

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Rediff.com15 Feb 2021

A study by researchers from the Indian Institute of Technology Bombay found that a droplet remains liquid for a much shorter time on a porous surface, making it less favourable to the survival of the virus.

First volunteer given COVID-19 vaccine in UK

First volunteer given COVID-19 vaccine in UK

Rediff.com24 Jun 2020

If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

India's IT spending likely to grow 19.5% in 04

India's IT spending likely to grow 19.5% in 04

Rediff.com24 Apr 2003

In 2004, India's IT spending is expected to grow 19.5 per cent, while that of China is forecast to expand 16.9 per cent, IDC said.\n\n\n\n

Delhi's Covid surge no sign of 4th wave, say health experts

Delhi's Covid surge no sign of 4th wave, say health experts

Rediff.com19 Apr 2022

Though Covid cases are rising in Delhi and its satellite towns, the focus should be on hospital admissions that have remained the same or changed just marginally, say several scientists, underscoring that the uptick is not an indication of a fourth wave in the country at this point.

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Air pollution may hinder India's fight against COVID-19: Scientists

Air pollution may hinder India's fight against COVID-19: Scientists

Rediff.com27 Oct 2020

Long-term exposure to chronically high PM2.5 levels weakens the ability of the lungs to fend off infections, therefore making people more susceptible to COVID-19, the scientists said.

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

Rediff.com10 Jan 2023

This doctor couple put their faith in India. And in return India has put faith in them.

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Oxford varsity enrols volunteers for Covid vaccine trial

Oxford varsity enrols volunteers for Covid vaccine trial

Rediff.com28 Mar 2020

The researchers, working in an 'unprecedented' vaccine development effort to prevent COVID-19, said they have started screening healthy volunteers (aged 18-55) from Friday for their upcoming trial in the Thames Valley Region of England.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

57% of Mumbai's slum dwellers have covid antibodies: Study

57% of Mumbai's slum dwellers have covid antibodies: Study

Rediff.com29 Jul 2020

The sero-surveillance started on June 3 and 6,936 samples out of an estimated 8,870 were collected from slum and non-slum population of three civic wards -- R-North, M-West and F-North -- in the first half of July.

Lockdown will no longer help in COVID-19 fight: Virologist

Lockdown will no longer help in COVID-19 fight: Virologist

Rediff.com23 May 2020

Shahid Jameel, recipient of Shanti Swarup Bhatnagar Prize for Science and Technology, also said that the country had already reached community transmission a long time ago.

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

Rediff.com15 Jul 2020

The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.

COVID-19 test method developed by IIT Delhi gets ICMR nod

COVID-19 test method developed by IIT Delhi gets ICMR nod

Rediff.com23 Apr 2020

IIT Delhi is the first academic institute to have obtained the ICMR approval for a real-time PCR- based diagnostic assay. The development also comes against the backdrop of the Indian Council of Medical Research halting the testing for COVID-19 cases through China-made test kits because of massive variation in test results, compounding the challenge to check and contain the pandemic.

Do people ever recover from COVID-19?

Do people ever recover from COVID-19?

Rediff.com29 Sep 2020

'People who have already got diabetes or heart disease or high blood pressure seem to be more badly affected by the disease.'

COVID-19 second wave: Delays in RT-PCR tests

COVID-19 second wave: Delays in RT-PCR tests

Rediff.com9 May 2021

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.

Covid: First Indian to get Trump cocktail discharged from hospital

Covid: First Indian to get Trump cocktail discharged from hospital

Rediff.com26 May 2021

Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the "single dose infusion-based treatment" on Tuesday and then kept under observation.

Most competitive economy: India's ranking slips

Most competitive economy: India's ranking slips

Rediff.com27 Sep 2017

On the list of 137 economies, Switzerland is followed by the US and Singapore in second and third places, respectively.

3rd wave may peak between Oct-Nov: Govt panel scientist

3rd wave may peak between Oct-Nov: Govt panel scientist

Rediff.com4 Jul 2021

However, Covid infection can spread faster during the third wave if any new virulent variant of SARS-CoV-2 emerges, said Manindra Agarwal who is working with the Sutra Model -- the mathematical projection of the COVID-19 trajectory.

Beam me up, Scotty! Indian tech firm helped in Wuhan's Covid-19 fight

Beam me up, Scotty! Indian tech firm helped in Wuhan's Covid-19 fight

Rediff.com30 Mar 2020

Thanks to technological support provided by BlinkIN, a Bengaluru-based intelligent visual-assistance company, engineers in Wuhan were able to remotely install air ventilation systems in two hospitals in Wuhan, the epicentre of the coronavirus pandemic, reports Peerzada Abrar.

Hong Kong's COVID-19 lessons for the world

Hong Kong's COVID-19 lessons for the world

Rediff.com22 Apr 2020

'The rate of transmission of COVID-19 in Hong Kong was 0.7 -- anything below 1 suggests the epidemic is receding.' 'The city-State achieved this without the de facto police-State curfew that India has resorted to,' says Rahul Jacob.

How US companies are helping India fight coronavirus

How US companies are helping India fight coronavirus

Rediff.com16 Apr 2020

A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.

Will a warmer summer help slow down coronavirus spread?

Will a warmer summer help slow down coronavirus spread?

Rediff.com2 Apr 2020

IMD has said the temperature in April-June across most parts in India is expected to be 0.5-1 degrees Celsius warmer than normal. However, doctors and scientists say they haven't found any direct correlation between the speed of COVID-19 spread and warm weather.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

'COVID-19 is a man made pandemic'

'COVID-19 is a man made pandemic'

Rediff.com6 Jun 2020

'Wild animals lived in their natural environment.' 'So, viruses could not be communicated.' 'Then came mass production and mass quartering of animals -- whether it be poultry, pigs and cattle -- which gave rise to bird flu, SARS and the mad cow disease.' 'Vast amounts of animal produce are also being flown from one part of the world to another, which has helped to spread the virus.' 'All these changes have led to a new and deadly mutation of the virus that has immobliised human beings.'

Hotter weather affects survival of coronavirus on surfaces

Hotter weather affects survival of coronavirus on surfaces

Rediff.com11 Jun 2020

The researchers said the growth rate of COVID-19 is weakly linked to the outdoor weather, adding that the chances of the survival of the virus "increases roughly by five times under a humid condition as compared to a dry condition."

Why finding COVID-19 vaccine won't be enough to end pandemic

Why finding COVID-19 vaccine won't be enough to end pandemic

Rediff.com13 May 2020

Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.

PSLV-C42 launch begins ISRO's new mission

PSLV-C42 launch begins ISRO's new mission

Rediff.com16 Sep 2018

Antrix, ISRO's commercial arm, is eyeing 10% of the $357 billion global market.

'Vaccinate, Vaccinate, Vaccinate!'

'Vaccinate, Vaccinate, Vaccinate!'

Rediff.com4 May 2021

'One thing we have learnt is that a pandemic can be arrested at any stage.' 'Not suddenly, of course, but slowly with steady unwavering focus.'

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

India approves Oxford's, Bharat Biotech's vaccines for emergency use

India approves Oxford's, Bharat Biotech's vaccines for emergency use

Rediff.com3 Jan 2021

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

India slips 10 spots to 68th on competitiveness index

India slips 10 spots to 68th on competitiveness index

Rediff.com9 Oct 2019

India is among the worst-performing BRICS nations along with Brazil (ranked even lower than India at 71st this year).